0001815476-23-000001.txt : 20230823
0001815476-23-000001.hdr.sgml : 20230823
20230823114508
ACCESSION NUMBER: 0001815476-23-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
EFFECTIVENESS DATE: 20230823
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Braxia Scientific Corp.
CENTRAL INDEX KEY: 0001815476
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-456582
FILM NUMBER: 231195946
BUSINESS ADDRESS:
STREET 1: 2300 - 1177 WEST HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6E2K3
BUSINESS PHONE: 6045259409
MAIL ADDRESS:
STREET 1: 2300 - 1177 WEST HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6E2K3
FORMER COMPANY:
FORMER CONFORMED NAME: Champignon Brands Inc.
DATE OF NAME CHANGE: 20200618
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001815476
Braxia Scientific Corp.
700 Bay Street
Ste 1903
Toronto
A6
ONTARIO, CANADA
M5G 1Z6
416 762-2138
BRITISH COLUMBIA, CANADA
Champignon Brands Inc.
Corporation
true
2019
Roger
S.
McIntyre
700 Bay Street
Suite 1903
Toronto
A6
ONTARIO, CANADA
M5G 1Z6
Executive Officer
Director
Peter
Rizakos
700 Bay Street
Suite 1903
Toronto
A6
ONTARIO, CANADA
M5G 1Z6
Executive Officer
Kevin
Kratiuk
700 Bay Street
Suite 1903
Toronto
A6
ONTARIO, CANADA
M5G 1Z6
Executive Officer
Jerry
Habuda
700 Bay Street
Suite 1903
Toronto
A6
ONTARIO, CANADA
M5G 1Z6
Director
Jason
Wolkove
700 Bay Street
Suite 1903
Toronto
A6
ONTARIO, CANADA
M5G 1Z6
Executive Officer
Other Health Care
Decline to Disclose
- 06b
true
0001815476-22-000006
2022-08-02
false
true
true
Convertible Debentures that can be converted into Common Shares of the Issuer prior to December 15, 2023, and expire on December 31, 2023
true
0
2283537
2283537
0
U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on August 2, 2022, which was CDN$1.2856 = USD$1.00.
false
35
0
0
0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
false
Braxia Scientific Corp.
/Peter Rizakos/
Peter Rizakos
General Counsel
2023-08-23